Skip to main content
Top
Published in: European Journal of Nutrition 1/2018

01-02-2018 | Original Contribution

Metabolic adaptations to HFHS overfeeding: how whole body and tissues postprandial metabolic flexibility adapt in Yucatan mini-pigs

Authors: Sergio Polakof, Didier Rémond, Annick Bernalier-Donadille, Mathieu Rambeau, Estelle Pujos-Guillot, Blandine Comte, Dominique Dardevet, Isabelle Savary-Auzeloux

Published in: European Journal of Nutrition | Issue 1/2018

Login to get access

Abstract

Purpose

In the present study, we aimed to metabolically characterize the postprandial adaptations of the major tissues involved in energy, lipids and amino acids metabolisms in mini-pigs.

Method

Mini-pigs were fed on high-fat–high-sucrose (HFHS) diet for 2 months and several tissues explored for metabolic analyses. Further, the urine metabolome was followed over the time to picture the metabolic adaptations occurring at the whole body level following overfeeding.

Results

After 2 months of HFHS consumption, mini-pigs displayed an obese phenotype characterized by high circulating insulin, triglycerides and cholesterol levels. At the tissue level, a general (muscle, adipose tissue, intestine) reduction in the capacity to phosphorylate glucose was observed. This was also supported by the enhanced hepatic gluconeogenesis potential, despite the concomitant normoglycaemia, suggesting that the high circulating insulin levels would be enough to maintain glucose homoeostasis. The HFHS feeding also resulted in a reduced capacity of two other pathways: the de novo lipogenesis, and the branched-chain amino acids transamination. Finally, the follow-up of the urine metabolome over the time allowed determining breaking points in the metabolic trajectory of the animals.

Conclusions

Several features confirmed the pertinence of the animal model, including increased body weight, adiposity and porcine obesity index. At the metabolic level, we observed a perturbed glucose and amino acid metabolism, known to be related to the onset of the obesity. The urine metabolome analyses revealed several metabolic pathways potentially involved in the obesity onset, including TCA (citrate, pantothenic acid), amino acids catabolism (cysteine, threonine, leucine).
Literature
1.
go back to reference Adochio RL, Leitner JW, Gray K, Draznin B, Cornier MA (2009) Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding. Nutr Metab 6:37CrossRef Adochio RL, Leitner JW, Gray K, Draznin B, Cornier MA (2009) Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding. Nutr Metab 6:37CrossRef
2.
go back to reference Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA (2000) Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272–283CrossRef Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA (2000) Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272–283CrossRef
3.
go back to reference Hoy AJ, Brandon AE, Turner N, Watt MJ, Bruce CR, Cooney GJ, Kraegen EW (2009) Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am J Physiol Endocrinol Metab 297:E67–E75CrossRef Hoy AJ, Brandon AE, Turner N, Watt MJ, Bruce CR, Cooney GJ, Kraegen EW (2009) Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am J Physiol Endocrinol Metab 297:E67–E75CrossRef
4.
go back to reference Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397–1403CrossRef Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397–1403CrossRef
5.
go back to reference Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A, Perlemuter G, Cassard-Doulcier AM, Gerard P (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62:1787–1794CrossRef Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A, Perlemuter G, Cassard-Doulcier AM, Gerard P (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62:1787–1794CrossRef
6.
go back to reference Machado MV, Ferreira DM, Castro RE, Silvestre AR, Evangelista T, Coutinho J, Carepa F, Costa A, Rodrigues CM, Cortez-Pinto H (2012) Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. PLoS One 7:e31738CrossRef Machado MV, Ferreira DM, Castro RE, Silvestre AR, Evangelista T, Coutinho J, Carepa F, Costa A, Rodrigues CM, Cortez-Pinto H (2012) Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. PLoS One 7:e31738CrossRef
7.
go back to reference Turner N, Kowalski GM, Leslie SJ, Risis S, Yang C, Lee-Young RS, Babb JR, Meikle PJ, Lancaster GI, Henstridge DC, White PJ, Kraegen EW, Marette A, Cooney GJ, Febbraio MA, Bruce CR (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56:1638–1648CrossRef Turner N, Kowalski GM, Leslie SJ, Risis S, Yang C, Lee-Young RS, Babb JR, Meikle PJ, Lancaster GI, Henstridge DC, White PJ, Kraegen EW, Marette A, Cooney GJ, Febbraio MA, Bruce CR (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56:1638–1648CrossRef
8.
go back to reference Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T (2010) Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One 5:e8817CrossRef Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T (2010) Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One 5:e8817CrossRef
9.
go back to reference Turner N, Cooney GJ, Kraegen EW, Bruce CR (2014) Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 220:T61–T79CrossRef Turner N, Cooney GJ, Kraegen EW, Bruce CR (2014) Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 220:T61–T79CrossRef
10.
go back to reference Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583–594CrossRef Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583–594CrossRef
11.
go back to reference Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453CrossRef Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453CrossRef
12.
go back to reference Xu F, Tavintharan S, Sum CF, Woon K, Lim SC, Ong CN (2013) Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. J Clin Endocrinol Metab 98:E1060–E1065CrossRef Xu F, Tavintharan S, Sum CF, Woon K, Lim SC, Ong CN (2013) Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. J Clin Endocrinol Metab 98:E1060–E1065CrossRef
13.
go back to reference Polakof S, Rémond D, Rambeau M, Pujos-Guillot E, Sébédio J-L, Dardevet D, Comte B, Savary-Auzeloux I (2014) Postprandial metabolic events in mini-pigs: new insights from a combined approach using plasma metabolomics, tissue gene expression, and enzyme activity. Metabolomics: 1–16 Polakof S, Rémond D, Rambeau M, Pujos-Guillot E, Sébédio J-L, Dardevet D, Comte B, Savary-Auzeloux I (2014) Postprandial metabolic events in mini-pigs: new insights from a combined approach using plasma metabolomics, tissue gene expression, and enzyme activity. Metabolomics: 1–16
14.
go back to reference Wishart DS (2007) Current progress in computational metabolomics. Brief Bioinform 8(5):279–293CrossRef Wishart DS (2007) Current progress in computational metabolomics. Brief Bioinform 8(5):279–293CrossRef
15.
go back to reference Zhu Y, Feng Y, Shen L, Xu D, Wang B, Ruan K, Cong W (2013) Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS). J Chromatogr B 925:110–116CrossRef Zhu Y, Feng Y, Shen L, Xu D, Wang B, Ruan K, Cong W (2013) Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS). J Chromatogr B 925:110–116CrossRef
16.
go back to reference Pedersen R, Ingerslev HC, Sturek M, Alloosh M, Cirera S, Christoffersen BO, Moesgaard SG, Larsen N, Boye M (2013) Characterisation of gut microbiota in Ossabaw and Gottingen minipigs as models of obesity and metabolic syndrome. PLoS One 8:e56612CrossRef Pedersen R, Ingerslev HC, Sturek M, Alloosh M, Cirera S, Christoffersen BO, Moesgaard SG, Larsen N, Boye M (2013) Characterisation of gut microbiota in Ossabaw and Gottingen minipigs as models of obesity and metabolic syndrome. PLoS One 8:e56612CrossRef
17.
go back to reference Guillerm-Regost C, Louveau I, Sebert SP, Damon M, Champ MM, Gondret F (2006) Cellular and biochemical features of skeletal muscle in obese Yucatan minipigs. Obesity (Silver Spring) 14:1700–1707CrossRef Guillerm-Regost C, Louveau I, Sebert SP, Damon M, Champ MM, Gondret F (2006) Cellular and biochemical features of skeletal muscle in obese Yucatan minipigs. Obesity (Silver Spring) 14:1700–1707CrossRef
18.
go back to reference Nielsen KL, Hartvigsen ML, Hedemann MS, Laerke HN, Hermansen K, Bach Knudsen KE (2014) Similar metabolic responses in pigs and humans to breads with different contents and compositions of dietary fibers: a metabolomics study. Am J Clin Nutr 99:941–949CrossRef Nielsen KL, Hartvigsen ML, Hedemann MS, Laerke HN, Hermansen K, Bach Knudsen KE (2014) Similar metabolic responses in pigs and humans to breads with different contents and compositions of dietary fibers: a metabolomics study. Am J Clin Nutr 99:941–949CrossRef
19.
go back to reference Litten-Brown JC, Corson AM, Clarke L (2010) Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. Animal 4:899–920CrossRef Litten-Brown JC, Corson AM, Clarke L (2010) Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. Animal 4:899–920CrossRef
20.
go back to reference Christoffersen B, Ribel U, Raun K, Golozoubova V, Pacini G (2009) Evaluation of different methods for assessment of insulin sensitivity in Göttingen minipigs: introduction of a new, simpler method. Am J Physiol Regul Integr Comp Physiol 297:R1195–R1201CrossRef Christoffersen B, Ribel U, Raun K, Golozoubova V, Pacini G (2009) Evaluation of different methods for assessment of insulin sensitivity in Göttingen minipigs: introduction of a new, simpler method. Am J Physiol Regul Integr Comp Physiol 297:R1195–R1201CrossRef
21.
go back to reference Spurlock ME, Gabler NK (2008) The development of porcine models of obesity and the metabolic syndrome. J Nutr 138:397–402CrossRef Spurlock ME, Gabler NK (2008) The development of porcine models of obesity and the metabolic syndrome. J Nutr 138:397–402CrossRef
22.
go back to reference Keppler D, Decker K, Bergmeyer HU (1974) Glycogen determination with amyloglucosidase. Methods of enzymatic analysis. Academic Press, New York, pp 1127–1131 Keppler D, Decker K, Bergmeyer HU (1974) Glycogen determination with amyloglucosidase. Methods of enzymatic analysis. Academic Press, New York, pp 1127–1131
23.
go back to reference Pereira H, Martin J-F, Joly C, Sébédio J-L, Pujos-Guillot E (2010) Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 6:207–218CrossRef Pereira H, Martin J-F, Joly C, Sébédio J-L, Pujos-Guillot E (2010) Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 6:207–218CrossRef
24.
go back to reference Benton HP, Wong DM, Trauger SA, Siuzdak G (2008) XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem 80:6382–6389CrossRef Benton HP, Wong DM, Trauger SA, Siuzdak G (2008) XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem 80:6382–6389CrossRef
25.
go back to reference Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779–787CrossRef Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779–787CrossRef
26.
go back to reference Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan TW, Fiehn O, Goodacre R, Griffin JL, Hankemeier T, Hardy N, Harnly J, Higashi R, Kopka J, Lane AN, Lindon JC, Marriott P, Nicholls AW, Reily MD, Thaden JJ, Viant MR (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3:211–221CrossRef Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan TW, Fiehn O, Goodacre R, Griffin JL, Hankemeier T, Hardy N, Harnly J, Higashi R, Kopka J, Lane AN, Lindon JC, Marriott P, Nicholls AW, Reily MD, Thaden JJ, Viant MR (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3:211–221CrossRef
27.
go back to reference Furet JP, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Dore J, Corthier G (2009) Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68:351–362CrossRef Furet JP, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Dore J, Corthier G (2009) Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68:351–362CrossRef
28.
go back to reference Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K (2008) Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 47:367–373CrossRef Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K (2008) Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 47:367–373CrossRef
29.
go back to reference Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70:7220–7228CrossRef Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70:7220–7228CrossRef
30.
go back to reference Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382CrossRef Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382CrossRef
31.
go back to reference Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K (2010) Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr 103:703–713CrossRef Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K (2010) Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr 103:703–713CrossRef
32.
go back to reference Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S (2010) Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22(512–519):e114–e515 Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S (2010) Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22(512–519):e114–e515
33.
go back to reference Ohene-Adjei S, Teather RM, Ivan M, Forster RJ (2007) Postinoculation protozoan establishment and association patterns of methanogenic archaea in the ovine rumen. Appl Environ Microbiol 73:4609–4618CrossRef Ohene-Adjei S, Teather RM, Ivan M, Forster RJ (2007) Postinoculation protozoan establishment and association patterns of methanogenic archaea in the ovine rumen. Appl Environ Microbiol 73:4609–4618CrossRef
34.
go back to reference Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101:541–550CrossRef Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101:541–550CrossRef
35.
go back to reference Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S (2007) Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 73:7767–7770CrossRef Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S (2007) Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 73:7767–7770CrossRef
36.
go back to reference Caraux G, Pinloche S (2005) PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21:1280–1281CrossRef Caraux G, Pinloche S (2005) PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21:1280–1281CrossRef
37.
go back to reference Sebert SP, Lecannu G, Kozlowski F, Siliart B, Bard JM, Krempf M, Champ MM (2005) Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes (Lond) 29:324–333CrossRef Sebert SP, Lecannu G, Kozlowski F, Siliart B, Bard JM, Krempf M, Champ MM (2005) Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes (Lond) 29:324–333CrossRef
38.
go back to reference Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718–15723CrossRef Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718–15723CrossRef
39.
go back to reference Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J, Zhang Q (2004) A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Pathol 85:223–231CrossRef Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J, Zhang Q (2004) A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Pathol 85:223–231CrossRef
40.
go back to reference Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M (2006) Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56:35–45 Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M (2006) Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56:35–45
41.
go back to reference Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339CrossRef Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339CrossRef
42.
go back to reference Croset M, Rajas F, Zitoun C, Hurot JM, Montano S, Mithieux G (2001) Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 50:740–746CrossRef Croset M, Rajas F, Zitoun C, Hurot JM, Montano S, Mithieux G (2001) Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 50:740–746CrossRef
43.
go back to reference Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376–388CrossRef Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376–388CrossRef
44.
go back to reference Stanhope KL (2012) Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annu Rev Med 63:329–343CrossRef Stanhope KL (2012) Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annu Rev Med 63:329–343CrossRef
45.
go back to reference Hellerstein MK (1999) De novo lipogenesis in humans: metabolic and regulatory aspects. Eur J Clin Nutr 53(Suppl 1):S53–S65CrossRef Hellerstein MK (1999) De novo lipogenesis in humans: metabolic and regulatory aspects. Eur J Clin Nutr 53(Suppl 1):S53–S65CrossRef
46.
go back to reference Mithieux G (2009) A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition 25:881–884CrossRef Mithieux G (2009) A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition 25:881–884CrossRef
47.
go back to reference Sejersen H, Sørensen MT, Larsen T, Bendixen E, Ingvartsen KL (2013) Liver protein expression in young pigs in response to a high-fat diet and diet restriction. J Anim Sci 91:147–158CrossRef Sejersen H, Sørensen MT, Larsen T, Bendixen E, Ingvartsen KL (2013) Liver protein expression in young pigs in response to a high-fat diet and diet restriction. J Anim Sci 91:147–158CrossRef
48.
go back to reference Iozzo P, Bucci M, Roivainen A, Någren K, Järvisalo MJ, Kiss J, Guiducci L, Fielding B, Naum AG, Borra R, Virtanen K, Savunen T, Salvadori PA, Ferrannini E, Knuuti J, Nuutila P (2010) Fatty acid metabolism in the liver, measured by positron emission tomography is increased in obese individuals. Gastroenterology 139(846–856):e846CrossRef Iozzo P, Bucci M, Roivainen A, Någren K, Järvisalo MJ, Kiss J, Guiducci L, Fielding B, Naum AG, Borra R, Virtanen K, Savunen T, Salvadori PA, Ferrannini E, Knuuti J, Nuutila P (2010) Fatty acid metabolism in the liver, measured by positron emission tomography is increased in obese individuals. Gastroenterology 139(846–856):e846CrossRef
49.
go back to reference Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15:606–614CrossRef Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15:606–614CrossRef
50.
go back to reference Lynch CJ, Adams SH (2014) Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev.Endocrinol 10(12):723–736CrossRef Lynch CJ, Adams SH (2014) Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev.Endocrinol 10(12):723–736CrossRef
51.
go back to reference Shin AC, Fasshauer M, Filatova N, Grundell LA, Zielinski E, Zhou JY, Scherer T, Lindtner C, White PJ, Lapworth AL, Ilkayeva O, Knippschild U, Wolf AM, Scheja L, Grove KL, Smith RD, Qian WJ, Lynch CJ, Newgard CB, Buettner C (2014) Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab 20:898–909CrossRef Shin AC, Fasshauer M, Filatova N, Grundell LA, Zielinski E, Zhou JY, Scherer T, Lindtner C, White PJ, Lapworth AL, Ilkayeva O, Knippschild U, Wolf AM, Scheja L, Grove KL, Smith RD, Qian WJ, Lynch CJ, Newgard CB, Buettner C (2014) Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab 20:898–909CrossRef
52.
go back to reference She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 293:E1552–E1563CrossRef She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 293:E1552–E1563CrossRef
53.
go back to reference Morio B, Comte B, Martin J-F, Chanseaume E, Alligier M, Junot C, Lyan B, Boirie Y, Vidal H, Laville M, Pujos-Guillot E, Sébédio J-L (2014) Metabolomics reveals differential metabolic adjustments of normal and overweight subjects during overfeeding. Metabolomics 11(4):920–938CrossRef Morio B, Comte B, Martin J-F, Chanseaume E, Alligier M, Junot C, Lyan B, Boirie Y, Vidal H, Laville M, Pujos-Guillot E, Sébédio J-L (2014) Metabolomics reveals differential metabolic adjustments of normal and overweight subjects during overfeeding. Metabolomics 11(4):920–938CrossRef
54.
go back to reference Lillefosse HH, Clausen MR, Yde CC, Ditlev DB, Zhang X, Du Z-Y, Bertram HC, Madsen L, Kristiansen K, Liaset B (2014) Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid Accretion by whey protein ingestion? J Proteome Res 13:2560–2570CrossRef Lillefosse HH, Clausen MR, Yde CC, Ditlev DB, Zhang X, Du Z-Y, Bertram HC, Madsen L, Kristiansen K, Liaset B (2014) Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid Accretion by whey protein ingestion? J Proteome Res 13:2560–2570CrossRef
55.
go back to reference Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Int Rev J 2:445–456CrossRef Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Int Rev J 2:445–456CrossRef
56.
go back to reference Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694–2698 Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694–2698
57.
go back to reference Sebert SP, Lecannu G, Kozlowski F, Siliart B, Bard JM, Krempf M, Champ MMJ (2005) Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes Relat Metab Disord 29:324–333CrossRef Sebert SP, Lecannu G, Kozlowski F, Siliart B, Bard JM, Krempf M, Champ MMJ (2005) Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes Relat Metab Disord 29:324–333CrossRef
58.
go back to reference Witczak CA, Mokelke EA, Boullion R, Wenzel J, Keisler DH, Sturek M (2005) Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55:445–451 Witczak CA, Mokelke EA, Boullion R, Wenzel J, Keisler DH, Sturek M (2005) Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55:445–451
Metadata
Title
Metabolic adaptations to HFHS overfeeding: how whole body and tissues postprandial metabolic flexibility adapt in Yucatan mini-pigs
Authors
Sergio Polakof
Didier Rémond
Annick Bernalier-Donadille
Mathieu Rambeau
Estelle Pujos-Guillot
Blandine Comte
Dominique Dardevet
Isabelle Savary-Auzeloux
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 1/2018
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1302-1

Other articles of this Issue 1/2018

European Journal of Nutrition 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.